Carolien Bierman

Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial

Elisa A. Rozeman, Alexander M. Menzies, Alexander C. J. van Akkooi et al. · The Lancet Oncology · 2019 · 498 citations

Oncology, Medicine, Melanoma +6

Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial

Irene L. M. Reijers, Alexander M. Menzies, Alexander C. J. van Akkooi et al. · Nature Medicine · 2022 · 322 citations · Full text

Surgical Oncology, Oncology, Prado Trial +10

Pathological response and tumour bed histopathological features correlate with survival following neoadjuvant immunotherapy in stage III melanoma

Robert V. Rawson, Chandra Mani Adhikari, Carolien Bierman et al. · Annals of Oncology · 2021 · 56 citations · Full text

Surgical removal of the index node marked using magnetic seed localization to assess response to neoadjuvant immunotherapy in patients with stage III melanoma

B. Schermers, Viola Franke, Elisa A. Rozeman et al. · British journal of surgery · 2019 · 54 citations · Full text

Clinicopathological Risk Factors for an Invasive Breast Cancer Recurrence after Ductal Carcinoma <i>In Situ</i> —A Nested Case–Control Study

Lindy L. Visser, Lotte E. Elshof, Michael Schaapveld et al. · Clinical Cancer Research · 2018 · 43 citations · Full text